"It is a huge privilege to work with talented and passionate colleagues on new therapies that can change people’s lives."
Attracted by Genentech’s focus on science and innovation, I joined Genentech in 2007. I had the privilege to work with talented and passionate colleagues on cross-disciplinary teams, to move a number of novel therapeutic molecules from research to clinical trials. It is extremely fulfilling to see the new therapies we worked on for years finally get approved by health authorities.
Anal Chem. 2014 May 20;86(10):5150-7.
My work focuses on developing analytical technologies and methods to characterize new drug therapies, and provides data to enable drug process and formulation decisions.